NCT05670470

A Prospective, Randomized, Investigator-blinded, Parallel, Multi-center, Phase 3 Trial

A Prospective, Randomized, Investigator-blinded, Parallel, Multi-center, Phase 3 Trial in Bowel Preparation for Colonoscopy

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 84 (actual)
• Sponsor: Taejoon Pharmaceutical Co., Ltd. · Industry
• Sex: All
• Age: 19 Years
• Healthy volunteers: Accepted

Summary

This is a prospective randomized study compared with active control arm.

Detailed description

This is a prospective randomized study compared with active control arm. The investigators compare the colon cleansing in patients undergoing colonoscopy.

Conditions

• Bowel Preparation

Interventions

Type	Name	Description
DRUG	CTP0303	Subjects who are randomized into group CTP0303 will receive bowel preparation from evening to next morning.
DRUG	Orafang Tab	Subjects who are randomized into group Orafang Tab will receive bowel preparation from evening to next morning.

Timeline

• Start date: 2022-09-21
• Primary completion: 2023-01-15
• Completion: 2023-01-31
• First posted: 2023-01-04
• Last updated: 2023-03-01

Locations

1 site across 1 country: South Korea